This episode explores the strategic necessity for In-Vitro Diagnostic (IVD) manufacturers to partner with specialized, full-service distributors when entering the Mexican market. We discuss the regulatory landscape governed by COFEPRIS, the critical role of the Mexican Registration Holder (MRH), and how an integrated distributor model not only facilitates market entry but also provides essential post-market support, including installation, maintenance, and navigating recent regulatory updates like those from July 2023. Key Questions: - What is COFEPRIS and what is its role in regulating IVD products in Mexico? - Why is a Mexican Registration Holder (MRH) mandatory for foreign manufacturers? - How does a brand-agnostic sourcing model benefit clinical laboratories? - What comprehensive services do integrated distributors offer beyond logistics? - How do specialized distributors help manufacturers stay compliant with evolving regulations? - What were the key IVD classification updates in the Mexican Pharmacopoeia as of July 10, 2023? - Why is post-market surveillance and technovigilance critical for maintaining market access? - How can a distributor partnership create a competitive advantage in the Mexican IVD market? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, streamlining global market access. We act as your local representative in over 30 markets, including Mexico, developing efficient pathways for regulatory approval with COFEPRIS. Our experts use advanced AI to compile and submit technical dossiers, manage post-market surveillance, and monitor regulatory changes, ensuring your market presence is secure. Whether you are a startup or a multinational, Pure Global provides scalable solutions to navigate complex environments. Visit us at https://pureglobal.com, contact info@pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai.
Show More
Show Less
3 mins